Literature DB >> 7696052

Osteocalcin levels in chronic osteomyelitis.

K M Peters1, T Rosendahl, K D Heller, R Weigmann, K W Zilkens.   

Abstract

Osteocalcin is a vitamin K-dependent bone protein synthesized by osteoblasts. In generalized bone disorders serum osteocalcin correlates with osteoblast activity. Bone resorption and new bone formation occur in chronic osteomyelitis, dependent on the level of inflammatory activity. In 17 patients with active chronic osteomyelitis undergoing surgery, the serum levels of osteocalcin, alkaline phosphatase and C-reactive protein were measured before and after treatment. The osteocalcin levels were within the normal range preoperatively (10.8 +/- 11.0 micrograms/l), in the early postoperative period, and at discharge. It is therefore not a helpful marker in the clinical management of this condition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7696052     DOI: 10.1007/bf00454739

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  14 in total

1.  [The importance of serological parameters in the diagnosis and therapy monitoring of osteoporosis].

Authors:  R Venbrocks; K J Münzenberg
Journal:  Z Orthop Ihre Grenzgeb       Date:  1991 Jan-Feb

2.  Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.

Authors:  P A Price; M K Williamson; J W Lothringer
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

Review 3.  Carboxylated calcium-binding proteins and vitamin K.

Authors:  P M Gallop; J B Lian; P V Hauschka
Journal:  N Engl J Med       Date:  1980-06-26       Impact factor: 91.245

4.  Serum osteocalcin in rheumatoid arthritis and other inflammatory arthritides: relation between inflammatory activity and the effect of glucocorticoids and remission inducing drugs.

Authors:  E A Ekenstam; S Ljunghall; R Hällgren
Journal:  Ann Rheum Dis       Date:  1986-06       Impact factor: 19.103

5.  The circadian rhythm of serum osteocalcin concentrations: effects of 1,25 dihydroxyvitamin D administration.

Authors:  M E Markowitz; C M Gundberg; J F Rosen
Journal:  Calcif Tissue Int       Date:  1987-04       Impact factor: 4.333

6.  Developmental appearance of the vitamin K-dependent protein of bone during calcification. Analysis of mineralizing tissues in human, calf, and rat.

Authors:  P A Price; J W Lothringer; S A Baukol; A H Reddi
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

7.  Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis.

Authors:  J P Brown; P D Delmas; L Malaval; C Edouard; M C Chapuy; P J Meunier
Journal:  Lancet       Date:  1984-05-19       Impact factor: 79.321

8.  New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.

Authors:  P A Price; J G Parthemore; L J Deftos
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

9.  [Osteocalcin and bone metabolism in rheumatoid arthritis and osteoarthritis].

Authors:  H Franck; F van Valen; E Keck; H L Krüskemper
Journal:  Z Rheumatol       Date:  1986 Sep-Oct       Impact factor: 1.372

10.  Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry.

Authors:  S A Charhon; P D Delmas; L Malaval; P M Chavassieux; M Arlot; M C Chapuy; P J Meunier
Journal:  J Clin Endocrinol Metab       Date:  1986-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.